These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23202890)

  • 1. Effects of intramolecular distance between amyloidogenic domains on amyloid aggregation.
    Ko A; Kim JR
    Int J Mol Sci; 2012 Sep; 13(10):12169-81. PubMed ID: 23202890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization and biological properties of the amyloidogenic elastin-like peptide (VGGVG)3.
    Moscarelli P; Boraldi F; Bochicchio B; Pepe A; Salvi AM; Quaglino D
    Matrix Biol; 2014 Jun; 36():15-27. PubMed ID: 24686253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.
    DuBay KF; Pawar AP; Chiti F; Zurdo J; Dobson CM; Vendruscolo M
    J Mol Biol; 2004 Aug; 341(5):1317-26. PubMed ID: 15302561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide study of the relationship between the collagen triple-helix and amyloid.
    Parmar AS; Nunes AM; Baum J; Brodsky B
    Biopolymers; 2012 Oct; 97(10):795-806. PubMed ID: 22806499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation properties of a short peptide that mediates amyloid fibril formation in model proteins unrelated to disease.
    Chaudhary N; Singh S; Nagaraj R
    J Biosci; 2011 Sep; 36(4):679-89. PubMed ID: 21857114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenic Propensities of Ribosomal S1 Proteins: Bioinformatics Screening and Experimental Checking.
    Grishin SY; Deryusheva EI; Machulin AV; Selivanova OM; Glyakina AV; Gorbunova EY; Mustaeva LG; Azev VN; Rekstina VV; Kalebina TS; Surin AK; Galzitskaya OV
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalently attached fatty acyl chains alter the aggregation behavior of an amyloidogenic peptide derived from human β(2)-microglobulin.
    Rawat A; Nagaraj R
    J Pept Sci; 2013 Dec; 19(12):770-83. PubMed ID: 24243599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.
    El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB
    Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidogenic potential of alpha-chymotrypsin in different conformational states.
    Rezaei-Ghaleh N; Zweckstetter M; Morshedi D; Ebrahim-Habibi A; Nemat-Gorgani M
    Biopolymers; 2009 Jan; 91(1):28-36. PubMed ID: 18767127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Aggregation and Fibril Formation Propensity of Peptides Involved in Amyloid Diseases.
    Malavolta L; Chinarelli RL; Sobral DV; Nakaie CR
    Protein Pept Lett; 2018 Feb; 24(12):1141-1147. PubMed ID: 29086671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
    Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
    J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
    Jayaraman M; Kodali R; Sahoo B; Thakur AK; Mayasundari A; Mishra R; Peterson CB; Wetzel R
    J Mol Biol; 2012 Feb; 415(5):881-99. PubMed ID: 22178474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.
    Vilasi S; Sarcina R; Maritato R; De Simone A; Irace G; Sirangelo I
    PLoS One; 2011; 6(7):e22076. PubMed ID: 21779376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidogenic sequences in native protein structures.
    Tzotzos S; Doig AJ
    Protein Sci; 2010 Feb; 19(2):327-48. PubMed ID: 20027621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.